A 28-year-old woman from Mumbai is suspected of having drug-resistant tuberculosis (MDR-TB). She has completed 4 months of standard anti-TB therapy with persistent positive sputum smears. Which investigation is most appropriate to detect rifampicin and isoniazid resistance?

Explanation

## Investigation of Choice for MDR-TB Detection **High-Yield:** GeneXpert MTB/RIF (rapid molecular test) followed by phenotypic drug susceptibility testing (DST) is the gold standard for detecting MDR-TB (resistance to both rifampicin and isoniazid). ### Diagnostic Algorithm for Suspected MDR-TB ```mermaid flowchart TD A[Suspected MDR-TB<br/>Persistent positive smear after 4 months]:::outcome --> B{GeneXpert MTB/RIF}:::decision B -->|MTB detected<br/>RIF-resistant| C[Confirm MDR-TB status]:::action B -->|MTB detected<br/>RIF-susceptible| D[Investigate treatment failure<br/>Poor adherence?]:::action C --> E[Phenotypic DST for INH<br/>and other drugs]:::action E --> F[Confirm MDR-TB<br/>RIF-R + INH-R]:::outcome F --> G[Start MDR-TB regimen]:::action ``` **Key Point:** GeneXpert MTB/RIF detects rifampicin resistance with >99% specificity. However, it does NOT detect isoniazid resistance directly — phenotypic DST is required to confirm MDR-TB (resistance to both RIF and INH). ### Why GeneXpert MTB/RIF Is the First-Line Rapid Test | Feature | GeneXpert MTB/RIF | Phenotypic DST | Sputum Smear | CT Chest | |---------|-------------------|-----------------|--------------|----------| | **Detects RIF resistance** | Yes, rapid (<2 hrs) | Yes (2–8 weeks) | No | No | | **Detects INH resistance** | No | Yes | No | No | | **Turnaround time** | <2 hours | 2–8 weeks | Immediate | Same day | | **Confirms MDR-TB** | Partial (RIF only) | Yes (RIF + INH) | No | No | | **Utility in treatment failure** | High (guides RIF status) | High (full DST) | Low | Supportive | **Clinical Pearl:** In India, NTEP guidelines recommend GeneXpert MTB/RIF as the first-line test for suspected MDR-TB. If RIF resistance is detected, phenotypic DST must follow to confirm INH resistance and establish full MDR-TB status before switching to MDR-TB regimen. **Mnemonic: RIF-FIRST** — **RIF** resistance detected first by GeneXpert; **FIRST**-line test for MDR-TB screening. ### Why Sputum Smear Microscopy Is Inadequate Sputum smear microscopy only confirms the presence of acid-fast bacilli (AFB) and bacterial load; it provides **no information about drug resistance**. Persistent positive smears after 4 months of therapy suggest either treatment failure due to resistance or poor adherence — smear microscopy cannot differentiate these. ### Why Phenotypic DST Alone Is Not First-Line Although phenotypic DST is the gold standard for confirming MDR-TB (detects both RIF and INH resistance), it takes 2–8 weeks. GeneXpert MTB/RIF provides rapid RIF resistance detection, allowing earlier initiation of MDR-TB regimen while DST results are pending. ### Why TST and CT Are Inappropriate - **Tuberculin skin test:** Screening tool; does not detect drug resistance. - **CT chest:** Supportive imaging; does not detect drug resistance or guide therapy.